Technology
Health
Biotechnology

CSL Limited

$71.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.65 (0.92%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell CSL Limited and other stocks, options, ETFs, and crypto commission-free!

About

Csl Ltd SPONSORED ADR (Australia), also called CSL Limited, is a biopharmaceutical company, which engages in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. Read More The CSL Behring segment provides plasma-derived and recombinant products, and operates plasma collection networks through CSL Plasma. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia. CSLLY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
22,220
Headquarters
Parkville, Victoria (VIC)
Founded
1961
Market Cap
64.41B
Price-Earnings Ratio
35.82
Dividend Yield
1.05
Average Volume
53.83K
High Today
$71.34
Low Today
$70.55
Open Price
$70.55
Volume
22.80K
52 Week High
$83.12
52 Week Low
$60.89

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Advertising and Marketing
Pharmaceutical
Business Services
2014 IPO

News

Yahoo FinanceMay 6

Should you buy CSL and these ASX healthcare shares?

Due to favourable tailwinds including ageing populations, improvements in treatments, and increased chronic disease burden, I believe the healthcare sector is a great place to consider making long term investments.

23
Yahoo FinanceMay 1

Why I would buy CSL and these ASX growth shares in May

If you’re a fan of growth shares then you’re in luck because I believe there are a large number of high quality ones to choose from on the Australian share market right now.

17
Yahoo FinanceApr 29

Best blue-chip shares: CSL boasts vaccine business “well placed to deliver further growth”

The CSL Limited (ASX: CSL) share price is flat at $198.60 today after the $90 billion healthcare giant gave a presentation to investors on the progress of its Seqirus influenza vaccine business at a Macquarie Group Ltd (ASX: MQG) organised equities conference in Sydney.

5
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.